Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Civamide Nasal Solution for Episodic Cluster Headache
NCT01341548Phase 3Not yet recruiting
- Sponsor
- Winston Laboratories, Inc.
- Start
- Nov 2023
- Primary completion
- Nov 2025
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of civamide in Cluster Headache (CH), sponsored by Winston Laboratories, Inc.. Planned start Nov 2023; status: not yet recruiting.
02
Drugs
civamide
03
Conditions
Cluster Headache (CH)
Beyond the preview
Go deeper on NCT01341548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01341548.